Chemours Historical Cash Flow
CC Stock | USD 25.91 0.57 2.15% |
Analysis of Chemours cash flow over time is an excellent tool to project Chemours future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Stock Based Compensation of 18.9 M or Free Cash Flow of 309.8 M as it is a great indicator of Chemours ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Chemours latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Chemours is a good buy for the upcoming year.
Chemours |
About Chemours Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Chemours balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Chemours's non-liquid assets can be easily converted into cash.
Chemours Cash Flow Chart
Chemours Cash Flow Statement became part of mandatory reporting in 1987. It is now one of three main statements in accounting used to measure how well a company manages its liquidity and overall cash position. The rate of cash utilization and preservation is now part of the leading indicators of a healthy entity, and the Chemours Cash Flow Statement shows how well the company generates cash to payout debt obligations or to cover ongoing operating expenses.
At present, Chemours' Stock Based Compensation is projected to increase significantly based on the last few years of reporting. The current year's Free Cash Flow is expected to grow to about 309.8 M, whereas Other Non Cash Items is forecasted to decline to about 6.7 M. Add Fundamental
Capital Expenditures
Capital Expenditures are funds used by Chemours to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Chemours operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from Chemours' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Chemours current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. At present, Chemours' Stock Based Compensation is projected to increase significantly based on the last few years of reporting. The current year's Free Cash Flow is expected to grow to about 309.8 M, whereas Other Non Cash Items is forecasted to decline to about 6.7 M.
2021 | 2022 | 2023 | 2024 (projected) | Begin Period Cash Flow | 1.1B | 1.6B | 1.1B | 1.2B | End Period Cash Flow | 1.6B | 1.3B | 1.8B | 1.3B |
Chemours cash flow statement Correlations
Click cells to compare fundamentals
Chemours Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Chemours cash flow statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change To Inventory | 116M | 126M | (202M) | (390M) | 58M | 60.9M | |
Stock Based Compensation | 19M | 16M | 34M | 27M | 18M | 18.9M | |
Free Cash Flow | 169M | 540M | 543M | 447M | 186M | 309.8M | |
Change In Working Capital | 138M | 356M | 27M | (104M) | 620M | 651M | |
Other Cashflows From Financing Activities | (30M) | 1.1B | (32M) | 43M | 724M | 760.2M | |
Depreciation | 311M | 320M | 317M | 291M | 307M | 313.9M | |
Other Non Cash Items | 399M | 16M | (89M) | (58M) | 7M | 6.7M | |
Capital Expenditures | 481M | 267M | 277M | 307M | 370M | 326.0M | |
Total Cash From Operating Activities | 650M | 807M | 820M | 754M | 556M | 635.8M | |
Change To Account Receivables | 128M | 12M | (225M) | 91M | (10M) | (9.5M) | |
Net Income | (52M) | 219M | 608M | 578M | (238M) | (226.1M) | |
Total Cash From Financing Activities | (419M) | (449M) | (560M) | (685M) | 172M | 180.6M | |
Other Cashflows From Investing Activities | (1M) | 6M | 497M | 20M | 23M | 21.9M | |
Sale Purchase Of Stock | (322M) | 12M | (173M) | (495M) | (69M) | (72.5M) | |
Investments | (2M) | 27M | (12M) | 3M | (229M) | (217.6M) | |
Change In Cash | (258M) | 162M | 446M | (247M) | 705M | 740.3M | |
Net Borrowings | 128M | (136M) | (29M) | (1M) | (900K) | (855K) | |
Total Cashflows From Investing Activities | (483M) | (234M) | 220M | (284M) | (326.6M) | (342.9M) | |
Change To Netincome | 263M | (76M) | (124M) | (10M) | (11.5M) | (12.1M) | |
Change To Liabilities | (169M) | 55M | 454M | 195M | 224.3M | 235.5M | |
Change Receivables | 191M | 175M | (225M) | 91M | 104.7M | 109.9M | |
Cash And Cash Equivalents Changes | (252M) | 124M | 480M | (215M) | (193.5M) | (183.8M) | |
End Period Cash Flow | 943M | 1.1B | 1.6B | 1.3B | 1.8B | 1.3B | |
Begin Period Cash Flow | 1.2B | 943M | 1.1B | 1.6B | 1.1B | 1.2B |
Pair Trading with Chemours
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemours position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemours will appreciate offsetting losses from the drop in the long position's value.Moving against Chemours Stock
0.63 | DNMR | Danimer Scientific Financial Report 8th of May 2024 | PairCorr |
0.58 | ECL | Ecolab Inc Financial Report 7th of May 2024 | PairCorr |
0.55 | CMT | Core Molding Technologies Financial Report 14th of May 2024 | PairCorr |
0.51 | ASH | Ashland Global Holdings Financial Report 7th of May 2024 | PairCorr |
0.49 | CBT | Cabot Financial Report 13th of May 2024 | PairCorr |
The ability to find closely correlated positions to Chemours could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chemours when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chemours - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chemours Co to buy it.
The correlation of Chemours is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chemours moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chemours moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chemours can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Chemours information on this page should be used as a complementary analysis to other Chemours' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Complementary Tools for Chemours Stock analysis
When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
Is Chemours' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.91) | Dividend Share 1 | Earnings Share (1.60) | Revenue Per Share 40.473 | Quarterly Revenue Growth 0.017 |
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.